• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Pfizer not backfilling Eliquis sales reps


<



Not good at all. Hearing rumors that another big layoff is coming, this time targeting Eliquis reps and others in CV. Meanwhile AL and the executive team is getting paid tens of millions of dollars in bonuses.
 
















Pfizer is still filling open Eliquis territories. A few vacant territories have been absorbed by surrounding territories, but most definitely new hires are being made to fill vacancies In most cases. Eliquis will be promoted through 2027.